KRT5 and urothelial carcinoma: In a large series of 32 patients with the plasmacytoid subtype, a significantly lower level of basal markers CK5/6 and p63 was demonstrated compared to conventional urothelial carcinoma, alongside high expression of luminal markers GATA3 and CK20 [5].